Cargo officer directing container equipment during a port inspection operation

Kratom International Trade: Customs, Documents, and Holds

July 15, 2026 at 7:52 pm

Trade and agency sources reviewed: July 15, 2026. Import and export requirements change by country, product, intended use, firm, shipment, and date. This material is general education, not legal advice or instructions for a particular transaction.

International kratom trade is not one handoff from a farmer to a store. A commercial shipment can involve an Indonesian processor and exporter, a freight forwarder, an ocean or air carrier, a U.S. importer of record, a licensed customs broker, U.S. Customs and Border Protection (CBP), the Food and Drug Administration (FDA), warehouses, laboratories, and insurers. Each participant sees a different part of the file.

That is why a shipment can be legal to export from one country yet still be detained or refused by the country of import. An invoice can be accurate while the product remains inadmissible. A laboratory report can describe a lot without satisfying customs-entry requirements. Clear terminology keeps those separate decisions from being mistaken for one universal “customs approval.”

The transaction has an export side and an import side

The exporting country controls what may leave, in which form, and with which permissions. The importing country controls what may enter, how it is classified and valued, which agencies review it, and whether it is admissible. The carrier also has document and security requirements, while the sales contract allocates commercial obligations between buyer and seller.

Indonesia provides a concrete example. Its current framework prohibits export of intact kratom leaf and specified material above 600 microns while regulating finer cut, crushed, or powdered material through registered exporters, export approval, and surveyor verification. Those Indonesian records do not bind a U.S. agency. The overseas importer must still satisfy U.S. entry and admissibility rules.

The economic and policy structure before the border is covered in Indonesia’s Kratom Economy: Smallholder Farming, Exports, and Policy.

Know which party owns which responsibility

Exporter or shipper: the foreign party named as sending the goods and responsible for the export-side transaction and documents assigned to it.
Seller: the party that invoices the buyer. The seller and exporter can be the same company, but they do not have to be.
Carrier: the ocean line, airline, trucker, courier, or other operator transporting cargo under a bill of lading or air waybill.
Freight forwarder: a logistics intermediary that can arrange bookings, consolidation, routing, and transport documents. A forwarder is not automatically the importer of record.
Consignee: the party identified to receive the goods. A consignee is not automatically the same as the buyer or importer of record.
Importer of record: the party legally responsible for the accuracy of the U.S. entry, classification, value, duties, and applicable entry requirements.
Customs broker: a CBP-licensed professional authorized to conduct customs business for the importer. CBP warns that using a broker does not transfer the importer of record’s ultimate responsibility for entry correctness.

These labels should match the actual contracts and filings. Treating a broker, courier, or foreign supplier as the party that “handles everything” creates gaps precisely where an agency expects a named responsible party.

The core commercial documents describe different facts

A document set is strongest when the same product identity, quantity, weights, lot references, parties, and route agree across the file.

Commercial invoice: identifies seller, buyer, goods, quantity, price, currency, and transaction terms. Customs uses invoice information in valuation and entry review.
Packing list: itemizes packages, marks, dimensions, net and gross weights, and contents. The U.S. International Trade Administration notes that it supports cargo checking but does not replace the commercial invoice.
Bill of lading or air waybill: records the transportation relationship and identifies shipper, consignee, cargo, route, and other carriage details. CBP describes a bill of lading as a receipt, contract of carriage, and, for applicable forms, a document of title.
Certificate or statement of origin: supports an origin claim when required by the destination, a buyer, a payment instrument, or a preference program. It is not universally required for every shipment in the same form.
Export authorization and surveyor records: support the exporting country’s requirements. For regulated Indonesian kratom, these can include registered-exporter status, export approval, and a surveyor report.
Laboratory and lot records: can support identity, composition, contaminants, or traceability. They describe the submitted sample and method; they are not a substitute for an entry, license, prior notice, or an agency admissibility decision.

A generic invoice description such as “herbal powder” may fail to communicate what the goods actually are. Accurate descriptions should identify the material and form without disguising the product. Quantity, weight, and package count should reconcile rather than forcing a reviewer to guess why one document says 500 kilograms and another describes 520 kilograms.

HS, HTS, and product descriptions are related but not identical

The World Customs Organization’s Harmonized System supplies the international six-digit structure used for most traded goods. Countries extend that structure with national tariff and statistical subdivisions. In the United States, the Harmonized Tariff Schedule (HTS) uses eight-digit legal rate lines and ten-digit statistical reporting numbers.

A code supplied by an Indonesian exporter is therefore not automatically the complete U.S. classification. Even when the first six digits align, later digits and national descriptions can differ. Product form, processing, composition, packaging, and intended use may affect the analysis. The U.S. International Trade Commission publishes the HTS, while CBP interprets and enforces it.

No single U.S. tariff number should be copied onto every kratom shipment from a general web page. An importer can search CBP’s published rulings and may request a prospective binding ruling with a detailed product description. A classification ruling addresses customs treatment; it does not compel FDA to admit a product that falls within FDA’s authority.

Cargo release and entry summary are separate U.S. steps

Carriers first transmit manifest information about arriving cargo. The importer or its authorized filer then presents entry information for cargo release. CBP’s entry-summary process uses Form 7501 data to assess duties, collect statistics, and determine whether other legal requirements have been met. CBP states that the entry summary and estimated duties generally must be filed or deposited within 10 working days after entry or release under the applicable process.

Electronic systems make the sequence faster, but they do not erase the distinctions:

the carrier reports the cargo;
the importer or broker files entry and partner-agency data;
CBP and any relevant agency review the shipment;
cargo may be released, held for documents, selected for examination, detained, or refused under the authority involved;
entry summary, duty, recordkeeping, and possible post-entry review continue after release.

“Released” is therefore not the same as “the government certified the product.” It means the cargo reached a particular release status in that transaction, subject to the agencies’ continuing powers and the importer’s obligations.

CBP and FDA answer different questions

CBP administers the customs entry, classification, valuation, origin, duties, and border coordination with other government agencies. FDA makes admissibility decisions for products within its jurisdiction under the Federal Food, Drug, and Cosmetic Act. CBP may hold cargo while FDA reviews it, and FDA may ask CBP to demand redelivery when product was conditionally released but needs to be returned.

For ordinary imported food, FDA describes requirements that can include foreign-facility registration, prior notice, and the Foreign Supplier Verification Programs rule. Those filings are not a permission slip for every substance or intended use. A timely prior notice tells FDA that covered food is arriving; it does not cure a substantive violation or override a product-specific import alert.

FDA Import Alert 54-15 directly addresses kratom

FDA’s current Import Alert 54-15 is titled “Detention Without Physical Examination of Dietary Supplements and Bulk Dietary Ingredients That Are or Contain Mitragyna speciosa or Kratom.” The alert identifies capsules, whole and processed leaves, resins, extracts, powder, and bulk extract liquids among the forms the agency has encountered.

The alert is more precise than the claim that every kratom shipment is automatically seized. FDA states that districts may detain specified products from firms on the alert’s Red List without physical examination. When an apparent kratom dietary supplement or bulk dietary ingredient is not already on that Red List, the alert directs districts to forward appropriate evidence as a Center Review Detention case. Marketing that makes drug claims can raise a separate unapproved- or misbranded-drug issue.

The practical consequence is still serious: correct freight documents and an Indonesian export approval do not resolve FDA’s stated concern. Importers should read the live alert, the listed firm and product information, and the FDA charge language before cargo moves. A historical copy or a supplier’s prior shipment experience is not a substitute for the current record.

A hold, examination, detention, refusal, and seizure are not synonyms

Manifest hold: CBP’s Manifest Examination Team can place a hold while it checks manifest information and requests supporting documents. This is an operational stop, not a final admissibility decision.
Examination or sample collection: an agency inspects documents, cargo, or a sample. The shipment remains pending until the relevant review is completed.
FDA detention: FDA issues a Notice of Detention and Hearing because the product appears to violate applicable law. The owner, consignee, importer of record, or authorized representative can present testimony to address the stated charge.
DWPE: detention without physical examination allows FDA to detain covered entries based on an import alert rather than first testing that individual shipment.
Refusal of admission: FDA determines that the product will not be admitted. FDA states that refused goods generally must be exported or destroyed with CBP and FDA coordination within 90 days.
Seizure: CBP takes property under an enforcement authority and sends a formal Notice of Seizure through its Fines, Penalties and Forfeitures process. A delayed or detained shipment has not necessarily been seized.

The notice controls. A carrier portal that displays “customs delay” cannot identify the legal charge, response deadline, or responsible agency with the precision of a CBP or FDA notice.

What happens after an FDA detention notice

FDA’s Notice of Detention and Hearing identifies the apparent violation and a respond-by date. The response opportunity is called a hearing, even when it occurs through written submissions, email, or telephone. Testimony can include information intended to overcome the appearance of the stated violation or, where allowed, a request to recondition the product.

Documents are normally submitted through FDA’s Import Trade Auxiliary Communication System or to the office named on the notice. FDA’s general guidance says the Regulatory Procedures Manual allows 10 business days from detention, while notices commonly account for weekends and mailing by providing up to about 20 calendar days. The actual date on the notice governs. If FDA does not receive a response, the compliance officer can issue a refusal.

A private laboratory report may be relevant for some charges, but it is not automatically decisive. The method, sampling, chain of custody, laboratory package, and specific legal issue all matter. A COA that measures lead and microbes does not answer a charge based on an unapproved new dietary ingredient. Use the kratom COA guide to read a report’s sample and scope, and the batch-number guide to check whether it belongs to the detained goods.

Document consistency is necessary even when admissibility is uncertain

A disciplined file does not guarantee release, but an inconsistent file can create its own problems. Before shipment, the parties should be able to reconcile:

the botanical and common identity of the goods;
whether the form is leaf, powder, capsule, extract, liquid, or another finished format;
manufacturer, seller, exporter, importer, and consignee names and addresses;
purchase-order, invoice, lot, package, and transport references;
net and gross weight, package count, and declared quantity;
country of origin and country of export;
the export-side permissions and the import-side product classification;
the live status of any applicable import alert or other agency restriction.

The right professional depends on the question. A freight forwarder can address routing and carriage. A customs broker can file entries and advise within the scope of licensed customs business. CBP can issue a binding classification ruling. The FDA office named on a notice controls an FDA entry response. Counsel is appropriate when a legal interpretation, enforcement exposure, or contested admissibility decision is involved.

Sources and further reading

Written By : Kratom Paradise Editorial Team